


Excitant Therapeutics
Biotechnology Research • Oklahoma City, Oklahoma, United States • 1-10 Employees
Company overview
| Headquarters | Oklahoma City, Oklahoma, United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Excitant Therapeutics
Henry Y Shin
Co-Founder and CEO
Excitant Therapeutics Email Formats
Excitant Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@excithera.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@excithera.com | 100% |
About Excitant Therapeutics
Excitant Therapeutics is a pre-clinical stage pharmaceutical company in Oklahoma. We are focused on developing novel therapeutic agents for ophthalmic diseases, especially those with dysfunctional microvasculature basis such as Diabetic Retinopathy, Diabetic Macular Edema, and Age-related Macular Degeneration. With our world-class scientific expertise in this field, we strive to translate our science to enhance the current standard of care for many ophthalmic diseases. Our Science, Your Vision!
Excitant Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Excitant Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Excitant Therapeutics has never raised funding before.
Excitant Therapeutics Tech Stack
Discover the technologies and tools that power Excitant Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Performance
Frequently asked questions
4.8
40,000 users



